Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 166 | 180 | 236 | 1,645 | 269 |
| Gross Profit | 166 | 180 | 236 | 1,645 | 269 |
| Operating Expenses | 41,950 | 47,230 | 40,591 | 39,368 | 40,141 |
| Operating Income | -41,784 | -47,050 | -40,355 | -37,723 | -39,872 |
| Interest Expense | 1,790 | 0 | 0 | 0 | 0 |
| Other Income | 888 | -1,042 | 979 | -1,807 | 882 |
| Pre-tax Income | -42,686 | -48,092 | -39,376 | -39,530 | -38,990 |
| Income Tax | -5,624 | -6,426 | -5,385 | -6,357 | -5,724 |
| Net Income Continuous | -37,062 | -41,666 | -33,991 | -33,173 | -33,266 |
| Net Income | $-37,062 | $-41,666 | $-33,991 | $-33,173 | $-33,266 |
| EPS Basic Total Ops | -0.41 | -0.50 | -0.47 | -0.47 | -0.53 |
| EPS Basic Continuous Ops | -0.41 | -0.50 | -0.47 | -0.47 | -0.53 |
| EPS Diluted Total Ops | -0.41 | -0.50 | -0.47 | -0.47 | -0.53 |
| EPS Diluted Continuous Ops | -0.41 | -0.50 | -0.47 | -0.47 | -0.53 |
| EBITDA(a) | $-39,717 | $-44,946 | $-37,907 | $-35,479 | $-38,210 |